Literature DB >> 23450874

Area-level socioeconomic disadvantage and severe pulmonary tuberculosis: U.S., 2000-2008.

Eyal Oren1, Masahiro Narita, Charles Nolan, Jonathan Mayer.   

Abstract

OBJECTIVES: Lower socioeconomic status (SES) is associated with increased risk of tuberculosis (TB) and diagnostic delays, but the extent to which this association reflects an underlying gradient in advanced status of pulmonary TB is unknown. We conducted a multilevel retrospective cohort analysis examining the relationship between socioeconomic characteristics and pulmonary TB disease status, as measured via sputum smears and chest radiography results.
METHODS: We included 862 incident TB patients reported in King County, Washington, from 2000-2008. We abstracted patient-level measures from charts and surveillance data. We obtained socioeconomic characteristics of TB patients, as well as those of the areas where TB patients lived, from the 2000 U.S. Census. A socioeconomic position (SEP) index was derived to measure SES.
RESULTS: Of those with known results, 814 of 849 patients (96%) displayed abnormal radiography findings. A total of 239 graded patients (39%) had positive smears, 136 (57%) of whom had grades of moderate (3+) or numerous (4+) acid-fast bacilli. In unadjusted analyses, patients living in lower SEP areas did not appear to have higher probabilities of more advanced disease. In multivariate models adjusting for individual demographic and socioeconomic measures, as well as area-based demographic variables, block-group SEP was not significantly associated with more advanced pulmonary disease.
CONCLUSIONS: Lower SEP was not significantly associated with greater pulmonary disease severity after controlling for individual age, race, sex, and origin, and block-group race, ethnicity, and origin. These findings suggest that the severity of pulmonary TB at diagnosis is not synonymous with delayed diagnosis.

Entities:  

Mesh:

Year:  2013        PMID: 23450874      PMCID: PMC3560867          DOI: 10.1177/003335491312800205

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  37 in total

1.  County characteristics and racial and ethnic disparities in the use of preventive services.

Authors:  Maureen R Benjamins; James B Kirby; Stephanie A Bond Huie
Journal:  Prev Med       Date:  2004-10       Impact factor: 4.018

2.  Patient and health care system delays in the diagnosis and treatment of tuberculosis.

Authors:  L F Sherman; P I Fujiwara; S V Cook; L B Bazerman; T R Frieden
Journal:  Int J Tuberc Lung Dis       Date:  1999-12       Impact factor: 2.373

3.  Equity of access to medical care: a conceptual and empirical overview.

Authors:  L A Aday; R M Andersen
Journal:  Med Care       Date:  1981-12       Impact factor: 2.983

4.  Pulmonary impairment after tuberculosis.

Authors:  Jotam G Pasipanodya; Thaddeus L Miller; Mauricio Vecino; Guadalupe Munguia; Robert Garmon; Sejong Bae; Gerry Drewyer; Stephen E Weis
Journal:  Chest       Date:  2007-03-30       Impact factor: 9.410

5.  Characteristics of patients with delayed diagnosis of infectious pulmonary tuberculosis.

Authors:  Lee-Lan Phoa; Monica D Teleman; Yee-Tang Wang; Cynthia B E Chee
Journal:  Respirology       Date:  2005-03       Impact factor: 6.424

6.  Tuberculosis and substance abuse in the United States, 1997-2006.

Authors:  John E Oeltmann; J Steve Kammerer; Eric S Pevzner; Patrick K Moonan
Journal:  Arch Intern Med       Date:  2009-01-26

7.  The role of area-level influences on prostate cancer grade and stage at diagnosis.

Authors:  Ann C Klassen; Frank C Curriero; Jean Hee Hong; Chyvette Williams; Martin Kulldorff; Helen I Meissner; Anthony Alberg; Margaret Ensminger
Journal:  Prev Med       Date:  2004-09       Impact factor: 4.018

8.  Delayed tuberculosis diagnosis and tuberculosis transmission.

Authors:  J E Golub; S Bur; W A Cronin; S Gange; N Baruch; G W Comstock; R E Chaisson
Journal:  Int J Tuberc Lung Dis       Date:  2006-01       Impact factor: 2.373

9.  Patient and health service delay in pulmonary tuberculosis patients attending a referral hospital: a cross-sectional study.

Authors:  Mpungu S Kiwuwa; Karamagi Charles; Mayanja Kizza Harriet
Journal:  BMC Public Health       Date:  2005-11-24       Impact factor: 3.295

Review 10.  A systematic review of delay in the diagnosis and treatment of tuberculosis.

Authors:  Dag Gundersen Storla; Solomon Yimer; Gunnar Aksel Bjune
Journal:  BMC Public Health       Date:  2008-01-14       Impact factor: 3.295

View more
  6 in total

Review 1.  A narrative review of tuberculosis in the United States among persons aged 65 years and older.

Authors:  Iris L Wu; Amit S Chitnis; Devan Jaganath
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2022-06-13

2.  Are we doing enough to stem the tide of acquired MDR-TB in countries with high TB burden? Results of a mixed method study in Chongqing, China.

Authors:  Ying Li; John Ehiri; Eyal Oren; Daiyu Hu; Xingneng Luo; Ying Liu; Daikun Li; Qingya Wang
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

3.  Race and nativity are major determinants of tuberculosis in the U.S.: evidence of health disparities in tuberculosis incidence in Michigan, 2004-2012.

Authors:  Grace A Noppert; Mark L Wilson; Philippa Clarke; Wen Ye; Peter Davidson; Zhenhua Yang
Journal:  BMC Public Health       Date:  2017-06-02       Impact factor: 3.295

4.  Social patterning of acute respiratory illnesses in the Household Influenza Vaccine Evaluation (HIVE) Study 2014-2015.

Authors:  Ryan E Malosh; Grace A Noppert; Jon Zelner; Emily T Martin; Arnold S Monto
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

5.  Contemporary Social Disparities in TB Infection and Disease in the USA: a Review.

Authors:  Grace A Noppert; Ryan E Malosh; Elizabeth B Moran; Shama D Ahuja; Jon Zelner
Journal:  Curr Epidemiol Rep       Date:  2018-09-28

6.  Understanding the intersection of race and place: the case of tuberculosis in Michigan.

Authors:  Grace A Noppert; Philippa Clarke; Margaret T Hicken; Mark L Wilson
Journal:  BMC Public Health       Date:  2019-12-11       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.